Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and PK of DF2755A in Healthy Volunteers
NCT04803396Phase 1Terminated
- Sponsor
- Dompé
- Start
- Nov 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of df2755a in bladder pain syndrome (BPS) and interstitial cystitis (IC) (5 arms), sponsored by Dompé. Primary endpoint: Number of Adverse Events by Severity at Day 4. Started Nov 2018; status: terminated.
02
Drugs
df2755a
03
Conditions
bladder pain syndrome (BPS)interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT04803396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803396.